Biocon Limited Share Price & Technical Analysis
BIOCON · ₹436.5 (+1.50%)
Healthcare / Biotechnology
₹436.5
+1.50%
Biocon Limited, together with its subsidiaries, manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics, Biosimilars, and Research segments. The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, multiple sclerosis, an…
Price chart
Seasonality
May has 4 positive and 1 negative years (last 5 years shown)
21% return in May, 4% avg return in past 3 year May month.
12% return in 2026, 13% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -7% | 5% | -5% | -3% | 21% | – | – | – | – | – | – | – | 12% |
| 25 | -1% | -17% | 12% | -5% | 4% | 6% | 10% | -11% | -2% | 9% | 7% | -1% | 11% |
| 24 | 7% | 3% | -4% | 12% | 3% | 12% | 3% | -1% | -1% | -13% | 15% | -3% | 34% |
| 23 | -10% | -3% | -11% | 11% | 5% | 7% | -4% | 0% | 5% | -18% | 8% | 4% | -7% |
| 22 | 1% | -5% | -4% | 9% | -8% | -8% | -1% | 0% | -3% | -7% | 4% | -8% | -31% |
Monthly return % by calendar month · historical pattern, not a forecast
Neutral · Strong · Overbought
Biocon Limited, together with its subsidiaries, manufactures and sells biotechnology products and research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics, Biosimilars, and Research segments. The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, multiple sclerosis, anti-fungal, anti-cancer, immunosuppressants, and specialty molecules; and biosimilars products consisting of pegfilgrastim, trastuzumab, bevacizumab, adalimumab, etanercept, ustekinumab, glargine, aspart, insulins, and aflibercept. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal healthcare, consumer goods, and agrochemical companies. In addition, the company offers enzyme, biopharmaceutical, and medicinal goods; contract research and manufacturing services, and other research and development in the fields of pharmaceuticals, drug discovery, biotechnology pharmaceuticals, and medicinal sciences, etc.; clinical research; and business support and development, and marketing services. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
₹651.70B
P/E ratio
143.22
52W high
₹440.4
52W low
₹327.6
Volume
71,01,933
Beta
0.23
Related stocks in Healthcare
Ngl Fine-chem Ltd.
₹2,260
Frequently asked questions
- What is Biocon Limited share price today?
- Biocon Limited (BIOCON) last traded around ₹436.5 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does BIOCON have?
- StockPro currently tracks 1 active signal(s) for BIOCON, including breakouts, momentum, and volume patterns. See the signals panel on this page.
- How can I analyze Biocon Limited stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.